Cholesterol & Lipid
Sort by:
National Lipid Association
ASCVD Therapy Update: Can Inclisiran Improve Adherence and Change Preventive Cardiology?
FEATURING
Christie Ballantyne
- 785 views
- March 19, 2020
- 4
The American Society for Preventive Cardiology
Assessment and Management of Severe Hypercholesterolemia
FEATURING
Amit Khera
- 783 views
- January 23, 2019
- 3
Cardiovascular Disease Management - 5th Annual Symposium
Can Heart Disease Eventually be Abolished? The PCSK9 Revolution
- 782 views
- December 27, 2017
- 1
Cedars Sinai
Primary Prevention of Cardiovascular Disease in Women: Blood Pressure, Lipids & Diabetes
FEATURING
Natalie Bello
- 781 views
- July 4, 2023
- 10
University of Louisville
Endocrine Escapades: Navigating the Nutraceutical Nexus
FEATURING
Sathya S. Krishnasamy
- 781 views
- April 23, 2024
- 5
Samuel Gidding
Familial Hypercholesterolemia: How to Diagnose and How to Treat? When Should We Screen for FH?
- 775 views
- December 11, 2020
- 2
National Lipid Association
What Should the Clinical Lipidologist Do with The REDUCE-IT Results?
FEATURING
Peter Howard Jones
- 775 views
- March 25, 2019
- 4
Preventative Cardiology Forum XXXIV
Pharmacologic Therapy for Prevention of Cardiovascular Disease
FEATURING
Amer Abdulla
- 770 views
- May 9, 2024
- 7
ASPC 2019 Congress on CVD Prevention
REDUCE-IT and Treating Beyond LDL-C Lowering
FEATURING
Deepak Bhatt
- 770 views
- August 9, 2019
- 8
MUSC Cardiology
Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients
FEATURING
Pamela B. Morris
- 758 views
- March 29, 2024
- 7
The American Society for Preventive Cardiology
Recommendations for Secondary ASCVD Prevention and Non-statin Drug Use
FEATURING
Salim Virani
- 752 views
- January 23, 2019
- 3
Top Ten Topics in Clinical Cardiology 2023
Role of CT Angiography in Indication for Revascularization: Equivocal or Forgotten?
FEATURING
Jagat Narula
- 750 views
- November 8, 2023
- 8
Stephen Kopecky
CV Outcomes Trials with PCSK9 Inhibitors – SPIRE, ODYSSEY, FOURIER and EBBINGHAUS
- 749 views
- August 18, 2017
- 2
National Lipid Association
Comparison 2013 and 2018 Cholesterol Guidelines in Primary Prevention
FEATURING
Neil Stone
- 746 views
- March 25, 2019
- 3
McMaster University Department of Medicine
Familial Hypercholesterolemia: What You Need to Know
FEATURING
Robert Hegele
- 732 views
- June 14, 2024
- 8
The North American Thrombosis Forum (NATF)
Current Treatments for LDL Lowering — and Why Patient Access Is So Important
- 729 views
- January 26, 2023
- 1
Canadian Collaborative Research Network
Inclisiran: the New LDL Kid on the Block
FEATURING
Milan Gupta
- 720 views
- June 13, 2022
- 2
Advances in Cardiovascular Disease Prevention
The Transformative Power of Lifestyle Medicine
FEATURING
Dean Ornish
- 719 views
- October 22, 2018
- 6
National Lipid Association
Comparison 2013 and 2018 Cholesterol Guidelines in Secondary Prevention
FEATURING
Carl Orringer
- 719 views
- March 25, 2019
- 6
Scripps Health
Personalized Medicine and Supplements in Prevention of ACSVD
- 718 views
- June 28, 2023
- 3
Canadian Collaborative Research Network
When to Use Ezetimibe or PCSK9 in Secondary Prevention
FEATURING
Jacques Genest
- 715 views
- June 13, 2022
- 1
National Lipid Association
Polygenic Risk Scoring for Lipids and Coronary Artery Disease
FEATURING
Pradeep Natarajan
- 711 views
- October 11, 2023
- 6